Ipsen and Debiopharm extend their agreement for the exclusive commercialization of Decapeptyl® (triptorelin pamoate) in Europe and certain other territories

This article or press release has no online content. Please download the associated documents for more information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2021